144 related articles for article (PubMed ID: 24990906)
1. Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.
Furfaro E; Mikulska M; Del Bono V; Guolo F; Minetto P; Gobbi M; Ghiso A; Bacigalupo A; Viscoli C
Clin Vaccine Immunol; 2014 Sep; 21(9):1357-9. PubMed ID: 24990906
[TBL] [Abstract][Full Text] [Related]
2. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
4. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
[TBL] [Abstract][Full Text] [Related]
6. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
7. Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.
Furfaro E; Giacobbe DR; Del Bono V; Signori A; Guolo F; Minetto P; Clavio M; Ballerini F; Gobbi M; Viscoli C; Mikulska M
Mycoses; 2018 Sep; 61(9):650-655. PubMed ID: 29693758
[TBL] [Abstract][Full Text] [Related]
8. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
[TBL] [Abstract][Full Text] [Related]
9. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.
De Vlieger G; Lagrou K; Maertens J; Verbeken E; Meersseman W; Van Wijngaerden E
J Clin Microbiol; 2011 Nov; 49(11):3783-7. PubMed ID: 21880959
[TBL] [Abstract][Full Text] [Related]
10. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
[TBL] [Abstract][Full Text] [Related]
11. Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections.
Bellanger AP; Grenouillet F; Henon T; Skana F; Legrand F; Deconinck E; Millon L
APMIS; 2011 Apr; 119(4-5):280-6. PubMed ID: 21492228
[TBL] [Abstract][Full Text] [Related]
12. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
13. Lack of 1-3-B-D-glucan detection in adults with bacteraemia.
Desjardins A; Parize P; Angebault C; Lécuyer H; Lortholary O; Bougnoux ME
Med Mycol; 2015 May; 53(4):405-8. PubMed ID: 25541560
[TBL] [Abstract][Full Text] [Related]
14. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
Hammarström H; Kondori N; Friman V; Wennerås C
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
[TBL] [Abstract][Full Text] [Related]
15. Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies--high frequency of false-positive results and their analysis.
Racil Z; Kocmanova I; Lengerova M; Weinbergerova B; Buresova L; Toskova M; Winterova J; Timilsina S; Rodriguez I; Mayer J
J Med Microbiol; 2010 Sep; 59(Pt 9):1016-1022. PubMed ID: 20488937
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.
Albert O; Toubas D; Strady C; Cousson J; Delmas C; Vernet V; Villena I
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1453-60. PubMed ID: 21479838
[TBL] [Abstract][Full Text] [Related]
17. Positive (1-3) B-d-glucan and cross reactivity of fungal assays in coccidioidomycosis.
Zangeneh TT; Malo J; Luraschi-Monjagatta C; Hage CA; Wheat LJ; Strawter C; Klotz SA; Knox KS
Med Mycol; 2015 Feb; 53(2):171-3. PubMed ID: 25541557
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.
Cai X; Ni W; Wei C; Cui J
Intern Med; 2014; 53(21):2433-7. PubMed ID: 25366000
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
20. No interference of the 1,3-β-D-glucan containing nutritional supplement ImunixX with the 1,3-β-D-glucan serum test.
Spriet I; Desmet S; Willems L; Lagrou K
Mycoses; 2011 Sep; 54(5):e352-3. PubMed ID: 20637053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
